Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tiny study sheds light on rare bacillus infections

NCT ID NCT03377530

Knowledge-focused Sponsor: Hôpital NOVO Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looked at 11 patients with severe infections caused by Bacillus bacteria, a germ that usually only harms people with weak immune systems. Researchers collected data to understand how patients get infected and what makes the infection dangerous. The goal is to find ways to prevent these serious infections in the future.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this research could point to better ways to prevent dangerous Bacillus infections in people with weak immune systems, like preterm infants.
What could go wrong
This is a very small, observational study (11 patients) that only describes past cases. It does not test any treatment, so it cannot directly lead to new therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

11 people

The number who actually took part.

Started

Jan 2008

Finished

Aug 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Newborns infected with Bacillus Species.

Ages

Up to 28 days

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * cases of Bacillus Species sepsis * cases of Bacillus species meningitis * with significant change in clinical status * Bacillus Species is the only organism isolated Exclusion Criteria: * Bacillus Species isolated with other organisms and Bacillus Species without clinical change were considered to be contaminants

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bacillus cereus infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bacillus cereus infection

Contacts and locations

Locations

  • Hôpital NOVO

    Cergy-Pontoise, 95300, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.